Company Filing History:
Years Active: 2008
Title: Juraj Koppel: Innovator in Pharmaceutical Compositions
Introduction
Juraj Koppel is a notable inventor based in Kosice, Illinois. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on thieno[2,3-c]pyridine derivatives. His research focuses on developing compositions that can address various diseases and disorders.
Latest Patents
Juraj Koppel holds a patent for "Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof." This invention provides thieno[2,3-C]pyridine derivatives, pharmaceutical compositions that include these derivatives, and methods for their use. The compounds developed by Koppel are capable of inhibiting glycosaminoglycan (GAG) interactions with effector cell adhesion molecules (ECAM). This innovation is particularly useful for treating inflammatory and autoimmune diseases, viral diseases, cancer, and amyloid disorders. He has 1 patent to his name.
Career Highlights
Koppel's career is marked by his dedication to pharmaceutical research and development. His work has the potential to impact the treatment of various serious health conditions, showcasing his commitment to advancing medical science.
Collaborations
Throughout his career, Juraj Koppel has collaborated with notable colleagues, including Paul Gregor and Nicholas Harris. These partnerships have contributed to the success of his research and the development of innovative pharmaceutical solutions.
Conclusion
Juraj Koppel is a distinguished inventor whose work in pharmaceutical compositions has the potential to transform treatment options for numerous diseases. His innovative approach and dedication to research continue to make a significant impact in the field.